BIOMAT Database Logo BIOMAT Database Logo

Clinical evaluation of a new recombinant antigen-based cytomegalovirus immunoglobulin M immunoassay in liver transplant recipients. 2001

V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

BACKGROUND Human cytomegalovirus (CMV) is a significant cause of morbidity and mortality among transplant recipients. Monitoring transplant recipients by CMV IgM serology has been questioned by several studies due to the reported insensitivity of serologic tests relative to antigen detection methods. METHODS In this retrospective study, we have evaluated the performance of the new recombinant antigen-based Abbott AxSYM CMV IgM assay and compared it with CMV culture technique in a cohort of 40 liver transplant recipients who did not receive antiviral prophylaxis. RESULTS The sensitivity, specificity, and positive and negative predictive values for detection of CMV disease by the AxSYM CMV IgM assay were 90.0%, 60.0%, 69.2%, and 85.7%, respectively, and by culture the values were 100%, 55.0%, 69.0%, and 100%, respectively. Detection of CMV IgM occurred before or at the time of CMV disease in only R+ recipients. CONCLUSIONS Although this assay is a sensitive test for CMV-specific IgM, detection of CMV IgM preceded detection of virus by culture in patients only when the liver transplant recipient was CMV immune before transplantation (R+).

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.
April 2000, Journal of clinical microbiology,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.
January 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Evaluation of a novel immunoglobulin A capture enzyme immunoassay for diagnosis of cytomegalovirus infection in renal and heart transplant recipients.
September 1997, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.
January 1987, Journal of clinical microbiology,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Evaluation of Abbott CMV-M enzyme immunoassay for detection of cytomegalovirus immunoglobulin M antibody.
October 1988, Journal of clinical microbiology,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Cytomegalovirus in liver transplant recipients.
August 2017, Current opinion in organ transplantation,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
June 2010, Journal of clinical pharmacology,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients.
June 2013, Transplant international : official journal of the European Society for Organ Transplantation,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Efficacy of cytomegalovirus immunoglobulin in marrow transplant recipients with cytomegalovirus pneumonia.
October 1987, The Journal of infectious diseases,
V W Halling, and G T Maine, and C M Groettum, and J A Wilson, and J Spesard, and S Brojanac, and B Combs, and D Wachta, and C Holas, and T Wilson, and D Wang, and S Tomazic-Allen, and T Lazzarotto, and M P Landini, and S Jevremovic-Simovic, and R H Wiesner, and C V Paya, and T F Smith
Cytomegalovirus infection in liver transplant recipients.
February 2002, Hepatobiliary & pancreatic diseases international : HBPD INT,
Copied contents to your clipboard!